Skip to main content
. 2019 Sep 30;20(19):4867. doi: 10.3390/ijms20194867

Figure 4.

Figure 4

Characterization of met-IPSC-derived kidney embryoid bodies. (A) Schematic representation of the generation of control or met-IPSC-derived kidney embryoid bodies and characterization of clinicopathological cancer markers cytokeratin 7, TFE3, and Cubilin. (B) Whole-mount staining for Cytokeratin 7, TFE3, LTL, Cubilin, and DAPI in control iPSC-derived kidney embryoid bodies. Scale bar: 500 μm. (C) Whole-mount staining for Cyto-keratin 7, TFE3, LTL, Cubilin, and DAPI in met-IPSC-derived kidney embryoid bodies. Scale bar: 500 μm.